Latest News

Canadians should aim to maximize their TFSAs whether they are conservative or more aggressive in their investing strategy.

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m

A high-yield stock operating within a specialized niche in the real estate sector pays monthly dividends.

The Shiller CAPE ratio is inching closer to the all-time highs of the dot-com bust in 2000.

Are you wondering how you can turn your TFSA into $1,000/month of tax-free income? Here's one strategy you could follow.

BigBear.ai and C3.ai aren't worth buying, but Broadcom still has a bright future.

It may seem like a bad idea, but it could work to your benefit.

ExlService (NASDAQ:EXLS) executives used the company’s 2026 Investor Day to outline a strategy centered on enterprise adoption of artificial intelligence, arguing that the company’s mix of data management, domain expertise and operations experience positions it for continued double-digit growth. Ch

The company's dependable dividend remains safe.

The team discusses hot, upcoming IPOs and how investors should be thinking about managing their portfolios in light of these new, exciting opportunities.

Here's how these two ETF giants compare on key factors such as risk, returns, and diversification.

What 300-year-old investing principles still apply today? What can Teddy Roosevelt’s cattle farm disaster teach us about modern stock picking? Historian, investor, and author Dr. Joseph S. Moore joins the show to discuss his new book, How to Get Rich in American History.

Motley Fool retirement expert Robert Brokamp provides 11 tips for making the most of your employer-sponsored retirement plan.

AMD looks poised to be a huge agentic AI winner.

Infleqtion uses similar technology to IonQ. Could it really outperform?

Elon Musk’s empire may be expanding if recent plans to spend up to $119 billion in new chip fab facilities become reality. The team discusses the implications for the industry and Musk’s companies.

A larger lifetime benefit could be just one move away.

This ETF is beating the Nasdaq and the S&P 500.

EverQuote (NASDAQ:EVER) Chief Financial Officer Joseph Sanborn said the online insurance marketplace is benefiting from a healthier property and casualty insurance industry as carriers shift from restoring underwriting profitability to pursuing policy growth. Speaking with Needham & Company ana

A look beyond the most basic of numbers quickly makes one of these a more reliable long-term income prospect.

After seeing enough demand, ARM Holdings said they, too, are getting into the semiconductor manufacturing business.

Top Wall Street analysts have maintained their bullish S&P 500 Index forecasts, pointing to the ongoing corporate earnings growth

The short-term risks of SoundHound's acquisition of LivePerson are weighing on the stock price.

Occidental Petroleum has multiple upside catalysts.